期刊文献+

TM6SF2 rs58542926 E167K单核苷酸多态性与非酒精性脂肪性肝病易感性的关系 被引量:2

The relationship between TM6SF2 rs58542926 E167K single nucleotide polymorphisms and the susceptibility of non-alcoholic fatty liver disease
下载PDF
导出
摘要 非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)是一种常见疾病,目前除了肥胖、高脂血症、糖尿病及胰岛素抵抗等危险因素外,遗传因素在其发病中起到的作用越来越受到重视。近期发现的TM6SF2 rs58542926 E167K单核苷酸多态性(single nucleotide polymorphisms,SNPs)与NAFLD的易感性明显相关,且有研究显示其与非酒精性脂肪性肝炎(nonalcoholic steatohepatitis,NASH)、肝纤维化及肝细胞癌(hepatocellular carcinoma,HCC)的发生同样相关。目前认为TM6SF2在体内参与肝细胞脂肪代谢,与极低密度脂蛋白(very low-density lipoprotein,VLDL)的分泌有关,TM6SF2 rs58542926 E167K突变导致该蛋白功能丧失,引起肝脏甘油三酯(triglyceride,TG)的过度积累,导致NAFLD的发生。 Non-alcoholic fatty liver disease(NAFLD) is a common disease,which is absolutely associated with features of the metabolic syndrome,including obesity,dyslipidaemia,type 2 diabetes mellitus( T2DM) and glucose intolerance. Much ongoing research is focused on identifying the genetic factors which contribute to NAFLD pathogenesis.Recently,TM6SF2 rs58542926 E167 K single nucleotide polymorphisms( SNPs) are demonstrated to be associated with NAFLD,the morbidity of nonalcoholic steatohepatitis( NASH),cirrhosis and hepatocellular carcinoma( HCC).TM6SF2 is required for very low-density lipoprotein( VLDL) secretion and TM6SF2 rs58542926 E167 K variant leads to lose the function of TM6SF2,which causally contributes to the attack of NAFLD.
作者 张爽 李异玲
出处 《胃肠病学和肝病学杂志》 CAS 2016年第4期367-370,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 非酒精性脂肪性肝病 TM6SF2 rs58542926 E167K 单核苷酸多态性 易感性 Nonalcoholic fatty liver disease TM6SF2 rs58542926 E167K Single nucleotide polymorphisms Susceptibility
  • 相关文献

参考文献24

  • 1Loomba R, Sanyal AJ. The global NAFLD epidemic [ J]. Nat Rev Gastroenterol Hepatol, 2013, 10( 11 ) : 686-690.
  • 2Brouwers MC, van Greevenbroek MM, Cantor RM. Heritability of non- alcoholic fatty liver disease [ J ]. Gastroenterology, 2009, 137 (4) : 1536.
  • 3Speliotes EK, Yerges-Arrnstrong LM, Wu J, et al. Genome-wide asso- ciation analysis identifies variants associated with nonalcoholic fatty liv- er disease that have distinct effects on metabolic traits [J]. PLoS Gen- et, 2011, 7(3) : e1001324.
  • 4Anstee QM, Day CP. The genetics of NAFLD [J]. Nat Rev Gastroen- terol Hepatol, 2013, 10( 11 ) : 645-655.
  • 5Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease [ J]. Nat Gen- et, 2008, 40(12) : 1461-1465.
  • 6Shen JH, Li YL, Li D, et al. The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysis [J].J Lipid Res, 2015, 56(1) : 167-175.
  • 7Liu YL, Patman GL, Leathart JB, et al. Carriage of the PNPLA3 rs738409 C > G polymorphism confers an increased risk of non-alcohol- ic fatty liver disease associated hepatocellular carcinoma [ J]. J Hepa- tel, 2014, 61(1) : 75-81.
  • 8Tr6po E, Nahon P, Bontempi G, et al. Association between the PNPLA3 (rs738409 C > G) variant and hepatocellular carcinoma: evi- dence from a meta-analysis of individual participant data [J]. Hepatol- ogy, 2014, 59(6) : 2170-2177.
  • 9Hernaez R, McLean J, Lazo M, et al. Association between variants inor near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Ex- amination Survey [ J ]. Clin Gastroenterol Hepatol, 2013, 11 (9) : 1183-1190, e2.
  • 10Aravinthan A, Mells G, Allison M, et al. Gene polymorphisms of cel- lular senescence marker p21 and disease progression in non-alcohol- related fatty liver disease [ J ]. Cell Cycle, 2014, 13 ( 9 ) : 1489-1494.

同被引文献15

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部